Donaco International Ltd (ASX:DNA) December Quarter 2018 Trading Update
Donaco In ternational Limited (ASX:DNA) provides the following trading update for the three month period ending December 2018.
Companies in the News
Travel
Collaborate Corporation Ltd (ASX:CL8) Secondary Trading Notice
Collaborate Corporation Limited (ASX:CL8) confirms that it has issued the following fully paid ordinary shares under the controlled placement deed with Acuity Capital.
Collaborate Corporation Ltd (ASX:CL8) Secures Controlled Placement Facility
Collaborate Corporation Limited (ASX:CL8) is pleased to announce the execution of a controlled placement deed with Acuity Capital for up to $3 million of equity over a 30-month period.
Donaco International Ltd (ASX:DNA) Senior Management Changes
Donaco International Ltd (ASX:DNA) announces that its Managing Director and Chief Executive Officer, Mr Joey Lim, has requested a leave of absence for a period expected to be approximately three months, to deal with health and personal matters.
Donaco International Ltd (ASX:DNA) AGM Addresses and Trading Update
In accordance with Listing Rule 3.13.3, Donaco International Limited (ASX:DNA) lodges the attached Chairman's address and Managing Director's address, to be delivered at today's Annual General Meeting of shareholders.
Collaborate Corporation Ltd (ASX:CL8) Canary Networks Investor Presentation - November 2018
Collaborate Corporation Limited (ASX:CL8) is pleased to release a copy of the Investor Presentation in advance of Collaborate's presentation to attendees at the Canary Networks Stocks to Watch Roadshow event in Sydney on 29 November.
Collaborate Corporation Ltd (ASX:CL8) December Quarter Performance Update and Key Product Launches
Collaborate Corporation Limited (ASX:CL8) (Collaborate or the Company) is pleased to provide an update on performance and key product launches in the December 2018 Quarter.
◂Previous Page
Travel Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
- Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis
Social Media
